Extrawell Pharmaceutical Holdings Limited (HKG:0858)
0.0810
-0.0010 (-1.22%)
At close: Feb 13, 2026
HKG:0858 Balance Sheet
Financials in millions HKD. Fiscal year is April - March.
Millions HKD. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
Cash & Equivalents | 92.7 | 77.77 | 93.61 | 102.4 | 111.88 | 126.71 |
Short-Term Investments | - | - | - | 0.75 | 0.74 | 0.75 |
Trading Asset Securities | 1.7 | 917.09 | 0.66 | 1.75 | 1.91 | 1.79 |
Cash & Short-Term Investments | 94.39 | 994.86 | 94.27 | 104.91 | 114.52 | 129.24 |
Cash Growth | -89.16% | 955.32% | -10.14% | -8.40% | -11.39% | 0.19% |
Accounts Receivable | 10.49 | 7.8 | 4.22 | 5.8 | 7.81 | 9.13 |
Other Receivables | 505.85 | 33.14 | 34.98 | 36.51 | 36.28 | 42.01 |
Receivables | 521.49 | 40.94 | 52.63 | 47.49 | 44.09 | 51.14 |
Inventory | 3.15 | 4.74 | 7.27 | 3.02 | 8.47 | 7.56 |
Prepaid Expenses | 0.99 | 1.14 | 1.13 | 2.54 | 1.4 | 0.8 |
Other Current Assets | 21.42 | 21.11 | 22.15 | 20.71 | 25.91 | 22.34 |
Total Current Assets | 641.44 | 1,063 | 177.44 | 178.66 | 194.38 | 211.08 |
Property, Plant & Equipment | 119.16 | 119.78 | 126.04 | 136.54 | 148.39 | 143.56 |
Long-Term Investments | 310.23 | 311.93 | 974.81 | 1,110 | 955.27 | 790.34 |
Goodwill | 1.81 | 1.81 | 1.81 | 1.81 | 1.81 | 1.81 |
Long-Term Deferred Tax Assets | 0.07 | 0.07 | 0.07 | 0.07 | 0.07 | 0.07 |
Other Long-Term Assets | 2.22 | 2.28 | 2.42 | 2.55 | 2.68 | 1.26 |
Total Assets | 1,098 | 1,526 | 1,287 | 1,445 | 1,317 | 1,164 |
Accounts Payable | 4.63 | 4.43 | 4.66 | 6.63 | 6.46 | 6.69 |
Accrued Expenses | 17.92 | 17.7 | 19.7 | 21.49 | 24.08 | 21.75 |
Current Portion of Leases | 1.14 | 1.9 | 1.38 | 1.32 | 2.19 | 1.77 |
Current Income Taxes Payable | 20.11 | 19 | 18.1 | 16.43 | 17.2 | 15.41 |
Current Unearned Revenue | 3.17 | 3.16 | 5.36 | 6.61 | 6.87 | 5.16 |
Other Current Liabilities | 2.13 | 2.31 | 2.18 | 4.53 | 7.26 | 7.12 |
Total Current Liabilities | 49.1 | 48.5 | 51.37 | 57.01 | 64.06 | 57.89 |
Long-Term Debt | 151.52 | 139.04 | 117.12 | 98.62 | 83.07 | 69.98 |
Long-Term Leases | 0.02 | - | 1.91 | 3.29 | 0.04 | 2.12 |
Long-Term Unearned Revenue | 4.04 | 4.01 | 4.17 | 4.38 | 5 | 4.95 |
Total Liabilities | 204.68 | 191.55 | 174.58 | 163.3 | 152.18 | 134.95 |
Common Stock | 25.5 | 23.9 | 23.9 | 23.9 | 23.9 | 23.9 |
Additional Paid-In Capital | 210.39 | 196.58 | 196.58 | 196.58 | 196.58 | 196.58 |
Retained Earnings | 210.96 | 670.69 | 448.04 | 610.99 | 481.73 | 351.14 |
Comprehensive Income & Other | 445.79 | 443.38 | 444.61 | 450.25 | 463.45 | 458.89 |
Total Common Equity | 892.64 | 1,335 | 1,113 | 1,282 | 1,166 | 1,031 |
Minority Interest | 0.71 | 0.26 | -0.51 | -0.15 | -0.73 | -1.21 |
Shareholders' Equity | 893.36 | 1,335 | 1,113 | 1,282 | 1,165 | 1,029 |
Total Liabilities & Equity | 1,098 | 1,526 | 1,287 | 1,445 | 1,317 | 1,164 |
Total Debt | 152.68 | 140.94 | 120.41 | 103.22 | 85.31 | 73.87 |
Net Cash (Debt) | -58.29 | 853.92 | -26.14 | 1.68 | 29.22 | 55.37 |
Net Cash Growth | - | - | - | -94.24% | -47.23% | -14.10% |
Net Cash Per Share | -0.02 | 0.26 | -0.01 | 0.00 | 0.01 | 0.02 |
Filing Date Shares Outstanding | 2,550 | 2,390 | 2,390 | 2,390 | 2,390 | 2,390 |
Total Common Shares Outstanding | 2,550 | 2,390 | 2,390 | 2,390 | 2,390 | 2,390 |
Working Capital | 592.34 | 1,014 | 126.07 | 121.65 | 130.32 | 153.19 |
Book Value Per Share | 0.35 | 0.56 | 0.47 | 0.54 | 0.49 | 0.43 |
Tangible Book Value | 890.84 | 1,333 | 1,111 | 1,280 | 1,164 | 1,029 |
Tangible Book Value Per Share | 0.35 | 0.56 | 0.46 | 0.54 | 0.49 | 0.43 |
Buildings | - | 118.88 | 120.17 | 122.84 | 136.49 | 137.58 |
Machinery | - | 62.02 | 61.42 | 55.61 | 52.77 | 49.4 |
Construction In Progress | - | 0.46 | 0.09 | 6.01 | 7.89 | - |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.